The biotech CytoDyn (OTCQB:CYDY) installed Cyrus Arman as president starting on July 9, 2022. Arman will assume the CEO role and join the company’s board within six months.
Before joining CytoDyn, Arman was the chief business officer at Nimble Therapeutics (Madison, Wisconsin), assuming that role on September 08, 2021.
“Early in the process, Dr. Arman separated himself from the competition, diving deep into due diligence with a methodical, analytical and inspired approach,” said Tanya Urbach, board chair, in a statement. “He has the intellectual capacity, experience, and character to lead CytoDyn into the future.”
Cyrys Arman
Arman has worked in the life sciences industry for more than 15 years, which includes working as a director in Amgen’s Corporate Strategy group.
He holds an MBA from the University of California, Los Angeles; a Ph.D. in neuroscience and a master’s degree in bi…